Cargando…
A review of validation strategies for computational drug repositioning
Repositioning of previously approved drugs is a promising methodology because it reduces the cost and duration of the drug development pipeline and reduces the likelihood of unforeseen adverse events. Computational repositioning is especially appealing because of the ability to rapidly screen candid...
Autores principales: | Brown, Adam S, Patel, Chirag J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862266/ https://www.ncbi.nlm.nih.gov/pubmed/27881429 http://dx.doi.org/10.1093/bib/bbw110 |
Ejemplares similares
-
A standard database for drug repositioning
por: Brown, Adam S., et al.
Publicado: (2017) -
ksRepo: a generalized platform for computational drug repositioning
por: Brown, Adam S., et al.
Publicado: (2016) -
MeSHDD: Literature-based drug-drug similarity for drug repositioning
por: Brown, Adam S, et al.
Publicado: (2017) -
Leveraging Population‐Based Clinical Quantitative Phenotyping for Drug Repositioning
por: Brown, Adam S., et al.
Publicado: (2018) -
Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma
por: Sagers, Jessica E., et al.
Publicado: (2018)